Hi, what are you looking for?
Israeli startup Orasis brings science fiction to life by developing corrective eye drops as an alternative to reading glasses, contact lenses or surgery.
These eye drops, made of a synthetic nanoparticle, can replace multifocal lenses so that people could see an object from various distances.
Mobileye, which nearly doubled from its IPO price of $25, stumbled 4.5% on a downgrade from Raymond James, which rated the stock...
Mobileye, the Israeli company that develops autonomous driving and driver-assist technologies and is owned by Intel, has once again been forced to lower its...
New research delves into the science of attraction, suggesting pupil dilation (size) could play a surprising role in how sexy someone appears.
In a breakthrough for diabetes management, scientists have developed a needle-free alternative to injections: oral insulin drops, also known as sublingual drops. Placed under...
The Israeli startup ecosystem, a beacon of innovation and entrepreneurial spirit, has faced a year of significant shifts and challenges.
Mobileye, it seems, will need to postpone its initial public offering (IPO), which the Israeli company owned by Intel that develops automated driving systems...
Using new technology from EyeYon, an Israeli medtech startup which develops and markets medical ophthalmic devices, Israeli doctors at the Shaare Zedek Medical Center...
The company just raised $25 million.